Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying therapeutic target genes for diabetic retinopathy using systematic druggable genome-wide Mendelian randomization. | Diabetol Metab Syndr | 2025 | 40301928 | PubTator, text mining | PubMed |
| P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. | Mol Carcinog | 2025 | 40099538 | PubTator, text mining | PubMed |
| Systematic Identification of Mitochondrial Signatures in Alzheimer's Disease and Inflammatory Bowel Disease. | Mol Neurobiol | 2025 | 40085351 | PubTator, text mining | PubMed |
| Retraction: Cell-Permeable NM23 Blocks the Maintenance and Progression of Established Pulmonary Metastasis. | Cancer Res | 2025 | 40083199 | PubTator, text mining | PubMed |
| Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner. | Mol Med | 2025 | 39910429 | PubTator, text mining | PubMed |
| 4D-DIA Proteomics Uncovers New Insights into Host Salivary Response Following SARS-CoV-2 Omicron Infection. | J Proteome Res | 2025 | 39803891 | PubTator, text mining | PubMed |
| Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in H3K27M-mutant gliomas. | bioRxiv | 2025 | 39803472 | PubTator, text mining | PubMed |
| Co-treatment with melatonin and ortho-topolin riboside exhibits anti-proliferation activity in radioresistant MDA-MB-231 cells by altering metabolic and transcriptomic profiles. | Biochem Biophys Res Commun | 2025 | 39667070 | PubTator, text mining | PubMed |
| Genetic Influence of the Brain on Muscle Structure: A Mendelian Randomization Study of Sarcopenia. | J Cachexia Sarcopenia Muscle | 2025 | 39535371 | PubTator, text mining | PubMed |
| Long Noncoding RNA NKX2-1-AS1 Accelerates Non-Small Cell Lung Cancer Progression through the miR-589-5p/NME1 Axis. | Cell Biochem Biophys | 2025 | 39117986 | PubTator, text mining | PubMed |
| Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis. | J Clin Transl Hepatol | 2024 | 39544249 | PubTator, text mining | PubMed |
| Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma. | Sci Rep | 2024 | 39251709 | PubTator, text mining | PubMed |
| Hsa_circ_ROBO1 competes with miR-324-3p and upregulates NME1 to promote tumor metastasis in nasopharyngeal carcinoma. | Discov Oncol | 2024 | 39222250 | PubTator, text mining | PubMed |
| Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes. | Respir Res | 2024 | 39217320 | PubTator, text mining | PubMed |
| Sensing with Molecularly Imprinted Membranes on Two-Dimensional Solid-Supported Substrates. | Sensors (Basel) | 2024 | 39204816 | PubTator, text mining | PubMed |
| Spatial transcriptome and single-cell reveal the role of nucleotide metabolism in colorectal cancer progression and tumor microenvironment. | J Transl Med | 2024 | 39075485 | PubTator, text mining | PubMed |
| Histidine Phosphorylation: Protein Kinases and Phosphatases. | Int J Mol Sci | 2024 | 39063217 | PubTator, text mining | PubMed |
| Nuclear NME1 enhances the malignant behavior of A549 cells and impacts lung adenocarcinoma patient prognosis. | iScience | 2024 | 39055952 | PubTator, text mining | PubMed |
| Kinase-catalyzed biotinylation for discovery and validation of substrates to multispecificity kinases NME1 and NME2. | J Biol Chem | 2024 | 39032654 | PubTator, text mining | PubMed |
| [Progress in enrichment methods for protein N-phosphorylation]. | Se Pu | 2024 | 38966971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=3